An executive order from President Trump aims to make deep cuts to prescription drug costs, putting GOP lawmakers who have ...

The markets have rewarded the Trump administration’s walkbacks, but the president is still a true believer in trade ...

President Donald Trump on Monday signed a sweeping executive order setting a 30-day deadline for drugmakers to ...

Novo Nordisk has potential with a 27% upside, strong market shares, and high ROI strategies. See why we recommend a buy on ...